Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 8 min ago
PreprintCC BY-NC-NDbioRxiv

Molecular Characterization of T-Lineage Acute Lymphoblastic Leukemia by an Optimal-Transport Based Multi-Omics Integration Framework

  1. 1University of Nebraska Medical Center

Abstract

T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive pediatric malignancy characterized by complex heterogeneity across multiple molecular layers. Accurate subtyping is essential for understanding disease mechanisms, risk stratification, and guiding targeted therapeutic strategies. However, current diagnostic approaches are labor-intensive and time-consuming, and existing computational methods are limited by reliance on single-modality data or simple integration strategies. Effective integration of heterogeneous multi-omics data remains a major computational challenge. We present OTTER (Optimal Transport-based Transcriptomics and gEnomics Representation), a novel multi-modal deep learning framework that jointly models transcriptomic and genomic data for T-ALL molecular characterization. OTTER encodes each omics modality through a modality-specific encoder and aligns the resulting latent representations using Gromov-Wasserstein optimal transport (GW-OT), which preserves the internal geometric structure of each modality without requiring a shared feature space. Benchmarking tests on the Children's Oncology Group (COG) AALL0434 cohort with >1,300 patients across 17 T-ALL subtypes suggested that OTTER significantly outperformed state-of-the-art approaches for T-ALL molecular characterization. In addition, OTTER could identify interpretable subtype-defining and omics-specific features for T-ALL. Furthermore, we have demonstrated the generalizability of OTTER by evaluating on multiple external independent clinical cohorts. In summary, OTTER provides a principled, biologically interpretable, and computationally effective framework for multi-omics driven T-ALL molecular characterization and broader cancer applications.

Related

  1. Chronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report
    Sushma Cherukuru, Surya Prakashrao, Sachin J +4
    CureusPeer-reviewedCC BYFull textGenetics & genomicsOncologyEurope PMCEurope PMCPMC
  2. Integration of molecular and cellular immunity in sea cucumbers: a comprehensive review
    Comparative Immunology ReportsPeer-reviewedCC BY-NCFull textImmunologyEurope PMC
  3. Multi-Omics Integration Drives Precision Breeding in Sorghum: Molecular Dissection and Breeding Practice
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
  4. Plant Responses to Heavy Metal Stress: Molecular Mechanisms, Transcriptomic Regulation, and Multi-Omics Integration in Crop Improvement
    Zagipa Sapakhova, Dias Daurov, Ainash Daurova +7
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
  5. miRAssist: a context-aware, evidence integration framework for interpretable miRNA-target prioritization
    A. Ring, Y. Xi
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
BibTeX
@misc{li2026molecular,
  title = {{Molecular Characterization of T-Lineage Acute Lymphoblastic Leukemia by an Optimal-Transport Based Multi-Omics Integration Framework}},
  author = {L. Li and J. Wang and S. Wan},
  howpublished = {bioRxiv},
  year = {2026},
  month = may,
  doi = {10.64898/2026.05.22.727257},
  url = {https://www.biorxiv.org/content/10.64898/2026.05.22.727257v2},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Molecular Characterization of T-Lineage Acute Lymphoblastic Leukemia by an Optimal-Transport Based Multi-Omics Integration Framework
AU  - L. Li
AU  - J. Wang
AU  - S. Wan
PY  - 2026
DA  - 2026/05/22
PB  - bioRxiv
DO  - 10.64898/2026.05.22.727257
UR  - https://www.biorxiv.org/content/10.64898/2026.05.22.727257v2
AB  - T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive pediatric malignancy characterized by complex heterogeneity across multiple molecular layers. Accurate subtyping is essential for understanding disease mechanisms, risk stratification, and guiding targeted therapeutic strategies. However, current diagnostic approaches are labor-intensive and time-consuming, and existing computational methods are limited by reliance on single-modality data or simple integration strategies. Effective integration of heterogeneous multi-omics data remains a major computational challenge. We present OTTER (Optimal Transport-based Transcriptomics and gEnomics Representation), a novel multi-modal deep learning framework that jointly models transcriptomic and genomic data for T-ALL molecular characterization. OTTER encodes each omics modality through a modality-specific encoder and aligns the resulting latent representations using Gromov-Wasserstein optimal transport (GW-OT), which preserves the internal geometric structure of each modality without requiring a shared feature space. Benchmarking tests on the Children's Oncology Group (COG) AALL0434 cohort with >1,300 patients across 17 T-ALL subtypes suggested that OTTER significantly outperformed state-of-the-art approaches for T-ALL molecular characterization. In addition, OTTER could identify interpretable subtype-defining and omics-specific features for T-ALL. Furthermore, we have demonstrated the generalizability of OTTER by evaluating on multiple external independent clinical cohorts. In summary, OTTER provides a principled, biologically interpretable, and computationally effective framework for multi-omics driven T-ALL molecular characterization and broader cancer applications.
ER  -